Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Inhibrx Biosciences (INBX) Receivables - Net (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Receivables - Net for 1 consecutive years, with $23000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Receivables - Net changed N/A to $23000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $23000.0, a N/A change, with the full-year FY2024 number at $23000.0, down 86.55% from a year prior.
  • Receivables - Net was $23000.0 for Q4 2024 at Inhibrx Biosciences, down from $600000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $600000.0 in Q3 2024 to a low of $23000.0 in Q4 2024.